UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                       Pursuant to Section 13 OR 15(d) of
                       the Securities Exchange Act of 1934

          Date of Report (Date of earliest event reported) May 25, 2006


                              INVACARE CORPORATION
- --------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)


         Ohio                       0-12938                      95-2680965
- --------------------------------------------------------------------------------
(State or other jurisdiction      (Commission               (IRS Employer
 of incorporation)                 File Number)              Identification No.)


One Invacare Way, P.O. Box 4028, Elyria, Ohio                           44036
- --------------------------------------------------------------------------------
(Address of principal executive offices)                             (Zip Code)

Registrant's telephone number, including area code: (440) 329-6000
                                                    --------------


- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report.)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)

[ ] Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))



Item 1.01.        Entry into a Material Definitive Agreement.

     On May 25,  2006,  Invacare  Corporation  (the  "Company")  held its Annual
Meeting of Shareholders,  where the Company's shareholders approved an amendment
to the Company's 2003  Performance Plan (the "Plan").  The amendment,  which was
approved  and  recommended  to the  Board  of  Directors  by  the  Compensation,
Management  Development  and Corporate  Governance  Committee  and  subsequently
approved,  subject to shareholder approval,  and recommended to the shareholders
by the Board of  Directors  on March 17,  2006,  increases  the number of common
shares of the Company  authorized  and reserved  for issuance  under the Plan by
1,800,000 shares from 2,000,000 to 3,800,000 common shares.

     The full text of the Plan, as amended,  was filed with the  Securities  and
Exchange Commission on April 7, 2006 as an Appendix to the Company's  Definitive
Proxy  Statement on Schedule 14A and is incorporated  by reference  herein.  The
description set forth above is qualified in its entirety by the Plan.

Item 5.02.        Departure of Directors or Principal Officers; Election of
                  Directors; Appointment of Principal Officers.

     As described by the Company in its Definitive  Proxy  Statement on Schedule
14A filed with the Securities and Exchange  Commission on April 7, 2006, Whitney
Evans elected to not stand for  re-election as a director of the Company and his
term as a director expired at the Company's Annual Meeting of Shareholders  held
on May 25,  2006  (the  "2006  Annual  Meeting").  In  order  to  rebalance  the
composition  of the Company's  Board of Directors,  at the 2006 Annual  Meeting,
Gerald B. Blouch  resigned as a director whose term will expire at the Company's
2007 annual meeting and was elected as a director of the Company whose term will
expire at the Company's 2009 annual meeting.




                                                        SIGNATURE

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                                        Invacare Corporation
                                                        (Registrant)

Date:  May 30, 2006                                     /s/ Gregory C. Thompson
                                                        ------------------------
                                                        Gregory C. Thompson
                                                        Chief Financial Officer